[1] Commission, N.H.A.F., Technical operation specifications for intravenous therapy nursing. China nursing management, 2014. 1(14): p. 1-4.
[2] Song, L., et al., Malposition of peripherally inserted central catheter: experience from 3012 cancer patients. Int J Nurs Pract, 2014. 20(4): p. 446-9.
[3] Chopra V, G.M.B.S., The Association between Upper and Lower Extremity Deep Vein Thrombosis and Peripherally Inserted Central Catheters: Think Below the Waist Annual Scientific Conference Abstract. Society of Hospital Medicine, 2014(Las Vegas, NV.).
[4] Olaf, M, et al., Deep Venous Thrombosis. Emerg Med Clin North Am, 2017. 35(4): p. 743-770.
[5] O'Brien J, et al. Insertion of PICCs with minimum number of lumens reduces complications and costs. J Am Coll Radiol. 2013;10:864–8.
[6] Aw A, et al. Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients. Thromb Res. 2012;130(3):323–6.
[7] Chemaly RF, et al. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis. 2002;34(9):1179–83.
[8] Cortelezzia A, et al. Central venous catheter-related complications in patients with hematological malignancies: a retrospective analysis of risk factors and prophylactic measures. Leuk Lymphoma. 2003;44(9):1495–501.
[9] King MM, et al. Peripherally inserted central venous catheter-associated thrombosis: retrospective analysis of clinical risk factors in adult patients. South Med J. 2006;99(10):1073–7.
[10] Paauw JD, et al. The incidence of PICC line-associated thrombosis with and without the use of prophylactic anticoagulants. JPEN J Parenter Enteral Nutr. 2008;32(4):443–7.
[11] Itkin M, et al. Peripherally inserted central catheter thrombosis – reverse tapered versus nontapered catheters: a randomized controlled study. J Vasc Interv Radiol. 2014;25(1):85–91.
[12] Liem, T.K., et al., Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. Journal of Vascular Surgery, 2012. 55(3): p. 761-767.
[13] Olson, J.D., D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications. Adv Clin Chem, 2015. 69(2): p. 1-46.
[14] Easaw, J.C., et al., Canadian consensus recommendations on the management of venous thromboembolism in patients with cancer. Part 2: treatment. Curr Oncol, 2015. 22(2): p. 144-55.
[15] Greene, M.T., et al., The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. The American Journal of Medicine, 2015. 128(9): p. 986-993.e1.
[16] Al-Asadi, O., M. Almusarhed and H. Eldeeb, Predictive risk factors of venous thromboembolism (VTE) associated with peripherally inserted central catheters (PICC) in ambulant solid cancer patients: retrospective single Centre cohort study. Thrombosis Journal, 2019. 17(2): p. 1-7.
[17] van der Straaten Mark Roest Fred Haas Philip G. De Groot Rob Fijnheer, F.H.J.H., Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis. the hematology journal, 2005. 4(90): p. 499-504.
[18] Chen Q, Z.Z.D.H. and Z.F.A.Z. Zhi., Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Clinical Significance of D-dimer. Zhongguo Fei Ai Za Zhi, 2019. 12(22): p. 761-766.
[19] Kanno, Y., et al., Elevation of plasma D-dimer is closely associated with venous thrombosis produced by double-lumen catheter in pre-dialysis patients. Nephrology Dialysis Transplantation, 2007. 22(4): p. 1224-1227.
[20] Zhang, D., et al., Diagnostic accuracy of biomarker D-dimer in patients after stroke suspected from venous thromboembolism: A diagnostic meta-analysis. Clinical Biochemistry, 2019. 63(2): p. 126-134.
[21] Jeffrey I. Weitz, M.A.B.C., A Test in Context : D-Dimer. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017. 70(19): p. 2411-2419.
[22] Lim, W., et al., American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv, 2018. 2(22): p. 3226-3256.
[23] Chopra, V., et al., Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet, 2013. 382(9889): p. 311-25.
[24] Greene, M.T., et al., The Association Between PICC Use and Venous Thromboembolism in Upper and Lower Extremities. The American Journal of Medicine, 2015. 128(9): p. 986-993.e1.
[25] CLSI. Quantitative D-dimer for exclusion of venous thromboembolic disease. CLSI
document H59-A. Wayne, PA: Clinical and Laboratory Standard Institute; 2011.
[26] Di Nisio M, Squizzato A, Rutjes AW, et al. Diagnostic accuracy of D-dimer test for exclusion of venous thromboembolism: a systematic review. J Thromb Haemost. 2007;5:296–304.
[27] Stein PD, Beemath A, Meyers FA, Skaf E, Sanchez J, Olson RE. Incidence of venous
thromboembolism in patients hospitalized with cancer. Am J Med. 2006;119(1):60-68.
[28] Menéndez JJ, Verdú C, Calderón B, et al. Incidence and risk factors of superficial and deep
vein thrombosis associated with peripherally inserted central catheters in children. J Thromb Haemost. 2016;14(11):2158-2168.
[29] . Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315-352.
[30] Heit, J. A. Epidemiology of venous thromboembolism. Nat Rev Cardiol. 2015;12(8):464-74.
[31] Heit, J. A. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis. 2006;21(1):23-9.
[32] Cote, L. P., et al. Comparisons Between Upper and Lower Extremity Deep Vein Thrombosis: A Review of the RIETE Registry. Clin Appl Thromb Hemost. 2017;23(7):748-754.
[33] Rokosh, R. S., et al. High Prevalence and Mortality Associated with Upper Extremity Deep Venous Thrombosis in Hospitalized Patients at a Tertiary Care Center. Ann Vasc Surg. 2020;65:55-65.
[34] Frolova, A.I., et al., Complications of peripherally inserted central catheters in pregnancy: a systematic review and meta-analysis. J Matern Fetal Neonatal Med, 2020.https://doi.org/10.1080/14767058.2020.1769591
[35] Jiang, M., et al., Risk of venous thromboembolism associated with totally implantable venous access ports in cancer patients: a systematic review and meta-analysis. J Thromb Haemost, 2020. https://doi.org/10.1111/jth.14930
[36] Heil, J., et al., Deep Vein Thrombosis of the Upper Extremity. Dtsch Arztebl Int, 2017. 114(14): p. 244-249.
[37] Fletcher, J. J., et al. The clinical significance of peripherally inserted central venous catheter-related deep vein thrombosis. Neurocrit Care. 2011;15(3):454-60.
[38] Gaffney PJ, Lane DA, Kakkar VV, et al. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. Thromb Res. 1975;7:89–99.
[39] Thachil J, Lippi G, Favaloro EJ. D-dimer testing: laboratory aspects and current issues. Methods Mol Biol. 2017;1646:91–104
[40] Lippi G, Cervellin G, Casagranda I, et al. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med. 2014;52:621–628.
[41] Karnrawee Kamolratanapiboon, Chaicharoen Tantanate. (2019) Inappropriate use of D-dimer and impact on the test characteristics for deep vein thrombosis exclusion. Scandinavian Journal of Clinical and Laboratory Investigation.2019;79(6):431-436.
[42] Linkins LA, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39 (Suppl 1):98–103.
[43] Lippi G, Bonfanti L, Saccenti C, et al. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25:45–48.
[44] Hattab, Y., et al., Deep Venous Thrombosis of the Upper and Lower Extremity. Crit Care Nurs Q, 2017. 40(3): p. 230-236.